2nd Annual Vascular Birthmarks Meeting: Trends and Innovation

Miami, FL US

2nd Annual Vascular Birthmarks Meeting: Trends and Innovation

Saturday, May 4, 2019

Nicklaus Children’s Hospital Main Auditorium

Learning Objectives

At the conclusion of this presentation, attendees are expected to:

  1. Diagnose an infantile hemangioma, a capillary malformation, a lymphatic malformation, a venous malformation, and an AV malformation
  2. Understand the latest developments in laser, interventional radiology, and surgical advances to recommend the best course of treatment for these conditions
  3. Understand the latest genetic developments associated with these conditions
  4. Understand the vast psychological effects of these conditions

Additional Information

AttachmentSize
Flyer.pdf68.68 KB
Course summary
Available credit: 
  • 2.50 AMA PRA Category 1 Credit™
    Nicklaus Children’s Hospital is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Nicklaus Children's Hospital designates this live activity for a maximum of AMA PRA Category Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Course opens: 
05/04/2019
Course expires: 
05/04/2019
Rating: 
0
Nicklaus Children’s Hospital - Main Auditorium
3100 SW 62nd Ave
Miami, FL 33155
United States

ACCREDITATION STATEMENT:

Nicklaus Children’s Hospital is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.


DESIGNATION STATEMENT:

Nicklaus Children’s Hospital designates this live activity for a maximum of 2.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


COMMERCIAL SUPPORT DISCLOSURE:

No Commercial Support was received for this Activity. The planning committee and staff have no conflicts of interest to declare.


FACULTY DISCLOSURE:

None of the speakers (and their spouses/partners) had any conflicts of interest or financial relationships to disclose in the past 12 months or plan to discuss unlabeled or investigational use of a drug, device, or product not approved in the U.S. except for the one(s) listed below:

Faculty/Moderator/or Planner

Person

Company

Role/ Relationship

Discussion of Investigational/Unlabeled Drugs or Devices

Ana Duarte, MD

Self

Self

Self

Self

Self

Pfizer

Novartis

Regeneron, Sanofi-Genzyme

Aclaris

Pierre-Fabre

Consulting Fee

Contracted Research

Consulting Fee

Contracted Research

Consulting Fee

None

Available Credit

  • 2.50 AMA PRA Category 1 Credit™
    Nicklaus Children’s Hospital is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Nicklaus Children's Hospital designates this live activity for a maximum of AMA PRA Category Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Please login or register to take this course.

This course has already taken place